Novartis AG
NVS | NYSE
$142.53
+$1.25 (+0.88%)
At close: Sep 23, 2026, 3:43 PM ET
$143.32
+$0.79 (+0.55%)
Pre-market:
Sep 24, 2026, 8:12 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 19.02 | 16.44 | 14.13 | 26.91 | 7.73 | 25.24 |
PEG Ratio | 0.85 | -0.96 | 0.11 | -0.38 | 0.04 | 1.88 |
PS Ratio | 4.88 | 3.80 | 4.50 | 4.31 | 4.22 | 4.08 |
PB Ratio | 5.79 | 4.46 | 4.49 | 3.16 | 2.74 | 3.60 |
P/FCF Ratio | 15.11 | 14.23 | 17.92 | 15.61 | 14.83 | 18.39 |
P/OCF Ratio | 13.89 | 11.15 | 14.51 | 13.15 | 12.32 | 14.91 |
OCF/S Ratio | 35.11 | 34.06 | 30.99 | 32.76 | 34.27 | 27.36 |
Debt / Equity Ratio | 0.80 | 0.71 | 0.56 | 0.47 | 0.46 | 0.67 |
Quick Ratio | 0.89 | 0.84 | 0.93 | 1.04 | 1.29 | 0.68 |
Current Ratio | 1.12 | 1.04 | 1.16 | 1.29 | 1.51 | 0.90 |
Asset Turnover | 0.47 | 0.51 | 0.47 | 0.37 | 0.33 | 0.38 |
Interest Coverage | 14.38 | 14.03 | 11.15 | 9.52 | 11.11 | 11.02 |
Return on Equity | 30.47% | 27.11% | 31.82% | 11.72% | 35.51% | 14.26% |
Return on Assets | 12.16% | 11.68% | 14.86% | 5.92% | 18.23% | 6.11% |
Return on Invested Capital | 15.50% | 15.55% | 11.49% | 7.06% | 8.69% | 7.61% |
Dividend Yield | 2.94% | 3.88% | 3.46% | 4.01% | 3.97% | 3.43% |
Payout Ratio | 55.91% | 63.85% | 48.86% | 107.92% | 30.67% | 86.56% |
FCF Payout Ratio | 44.43% | 59.74% | 66.93% | 66.98% | 62.36% | 67.66% |
Gross Profit Margin | 75.02% | 75.20% | 73.27% | 73.35% | 73.31% | 69.70% |
Net Profit Margin | 25.64% | 23.09% | 31.83% | 16% | 54.63% | 16.18% |
Pretax Profit Margin | 29.99% | 26.37% | 19.55% | 16.51% | 55.78% | 19.80% |
Operating Profit Margin | 31.15% | 28.12% | 20.94% | 18.28% | 22.87% | 20.35% |
FCF Margin | 32.27% | 26.69% | 25.09% | 27.60% | 28.46% | 22.18% |
EBITDA Margin | 41.94% | 40.05% | 39.12% | 33.78% | 70.30% | 34.49% |
Add to Watchlist
Select watchlists to add or remove NVS